2016 has been a tough year healthcare giant Johnson & Johnson (J&J). The company lost several multimillion dollar baby powder cancer trials, lost a $70 million Risperdal trial, and...
Blood thinners are a common treatment for patients suffering from conditions like deep vein thrombosis (DVT), atrial fibrillation (AFib), or for patients who are at an increased risk of...
While more than 7,000 Xarelto lawsuits have been consolidated in a multidistrict litigation (MDL) to the Eastern District of Louisiana, there are nearly 1,000 cases pending in a Philadelphia...
With more than 9,000 Xarelto lawsuits currently pending in three different venues, the first MDL bellwether trials in Louisiana will be pivotal. After a heated debate, the first four...
Atrial fibrillation (AFib), or an irregular heartbeat, affects nearly 2.7 million Americans. The irregular heartbeat causes poor bloodflow, which increases a person’s risk of suffering a heart attack or...
Although two bellwether cases for the Xarelto litigation have been postponed by one month, the litigation is still traveling full speed ahead. Manufacturers Janssen Pharmaceuticals (a subsidiary of Johnson...
Plaintiffs in the Xarelto litigation have waited for some time to face drug manufacturers in court, but they will have to wait just a little longer. The U.S. District...
As Janssen Pharmaceuticals and Bayer A.G. face more than 7,000 Xarelto lawsuits, a new study was published that will likely add to the company’s fears. A study published in...
With more than 7,000 lawsuits currently pending against Xarelto manufacturers, the litigation is reaching a fever pitch. Because of an increase in filings, plaintiffs were recently given an additional...
The controversy surrounding the anticoagulant Xarelto is reaching a fevered pitch, and the British Medical Journal (BMJ) just added more fuel to the fire. Johnson & Johnson (J&J) subsidiary...
